ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 23 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $14,941,000 | -16.5% | 14,690,000 | -10.5% | 0.00% | 0.0% |
| Q4 2020 | $17,895,000 | +34.2% | 16,415,000 | +26.1% | 0.00% | 0.0% |
| Q3 2020 | $13,338,000 | -10.5% | 13,015,000 | -3.7% | 0.00% | 0.0% |
| Q2 2020 | $14,896,000 | -7.1% | 13,515,000 | -14.1% | 0.00% | 0.0% |
| Q1 2020 | $16,026,000 | -37.2% | 15,740,000 | -29.4% | 0.00% | -50.0% |
| Q4 2019 | $25,505,000 | +6.8% | 22,290,000 | +6.7% | 0.00% | 0.0% |
| Q3 2019 | $23,878,000 | -3.6% | 20,890,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $24,758,000 | -9.0% | 20,890,000 | +4.1% | 0.00% | 0.0% |
| Q1 2019 | $27,208,000 | +24.1% | 20,065,000 | -1.7% | 0.00% | 0.0% |
| Q4 2018 | $21,916,000 | -11.6% | 20,415,000 | -12.6% | 0.00% | 0.0% |
| Q3 2018 | $24,788,000 | +11.1% | 23,365,000 | +2.9% | 0.00% | 0.0% |
| Q2 2018 | $22,304,000 | +4.3% | 22,715,000 | +5.3% | 0.00% | 0.0% |
| Q1 2018 | $21,378,000 | -4.5% | 21,565,000 | +2.1% | 0.00% | 0.0% |
| Q4 2017 | $22,394,000 | +13.6% | 21,115,000 | +14.0% | 0.00% | 0.0% |
| Q3 2017 | $19,717,000 | +9.1% | 18,515,000 | +8.5% | 0.00% | 0.0% |
| Q2 2017 | $18,068,000 | +29.8% | 17,065,000 | +18.0% | 0.00% | +100.0% |
| Q1 2017 | $13,924,000 | +2.8% | 14,465,000 | +9.0% | 0.00% | 0.0% |
| Q4 2016 | $13,539,000 | +100.7% | 13,265,000 | +40.1% | 0.00% | 0.0% |
| Q2 2016 | $6,745,000 | -21.8% | 9,465,000 | +0.5% | 0.00% | 0.0% |
| Q1 2016 | $8,621,000 | – | 9,415,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 7,000,000 | $6,536,000 | 3.36% |
| Sonora Investment Management, LLC | 15,550,000 | $14,486,691,000 | 3.04% |
| Jabre Capital Partners S.A. | 7,550,000 | $7,050,000 | 0.96% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,972,000 | $66,281,000 | 0.96% |
| MACKAY SHIELDS LLC | 10,243,000 | $9,558,000 | 0.43% |
| ARISTEIA CAPITAL, L.L.C. | 7,500,000 | $6,998,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 27,100,000 | $25,384,000 | 0.33% |
| SSI INVESTMENT MANAGEMENT LLC | 2,671,000 | $2,485,000 | 0.22% |
| Verition Fund Management LLC | 2,000,000 | $1,866,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,849,000 | $5,453,000 | 0.19% |